{
    "title": "AstraZeneca-Daiichi drug halts cancer for months in first readout",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-7780847/AstraZeneca-Daiichi-drug-halts-cancer-months-readout.html",
    "date": "2019-12-11",
    "keywords": [
        "cancer",
        "treatment",
        "astrazeneca",
        "drug",
        "breast",
        "benefit",
        "daiichi",
        "study",
        "deal",
        "line",
        "dec",
        "sankyo",
        "bay",
        "ds8201",
        "progression",
        "median",
        "head",
        "oncology",
        "research",
        "development",
        "patient",
        "group",
        "deterioration",
        "antibodydrug",
        "conjugate",
        "cell",
        "chemotherapy",
        "licensing",
        "collaboration",
        "march",
        "drugmaker",
        "partner",
        "share",
        "issue",
        "cash",
        "flow",
        "baselga",
        "approach",
        "one",
        "destinybreast01",
        "later",
        "lung",
        "therapy",
        "disease",
        "goal",
        "trial",
        "request",
        "approval",
        "food",
        "administration",
        "antonio",
        "symposium",
        "week",
        "reporting",
        "pushkala",
        "aripaka",
        "bengaluru",
        "burger",
        "frankfurt",
        "editing",
        "gopakumar",
        "warrierkeith",
        "weiralexander",
        "smith"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}